Tonya N. Taylor, Ph.D.

University of Oxford, Oxford, United Kingdom 
"Tonya Taylor"
Mean distance: 17.57 (cluster 32)


Sign in to add mentor
Gary W. Miller grad student 2005-2010 Emory
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wobst HJ, Denk F, Oliver PL, et al. (2017) Increased 4R tau expression and behavioural changes in a novel MAPT-N296H genomic mouse model of tauopathy. Scientific Reports. 7: 43198
Alter SP, Stout KA, Lohr KM, et al. (2015) Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degeneration. Experimental Neurology
Taylor TN, Potgieter D, Anwar S, et al. (2014) Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse. Neurobiology of Disease. 62: 193-207
Taylor TN, Alter SP, Wang M, et al. (2014) Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus. Neuropharmacology. 76: 97-105
Janezic S, Threlfell S, Dodson PD, et al. (2013) Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proceedings of the National Academy of Sciences of the United States of America. 110: E4016-25
Alter SP, Taylor TN, Sullivan P, et al. (2013) Progressive Noradrenergic Degeneration in Mice with Reduced Expression of the Vesicular Monoamine Transporter (VMAT2) Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 125
Taylor TN, Caudle WM, Miller GW. (2011) VMAT2-Deficient Mice Display Nigral and Extranigral Pathology and Motor and Nonmotor Symptoms of Parkinson's Disease. Parkinson's Disease. 2011: 124165
Taylor TN, Greene JG, Miller GW. (2010) Behavioral phenotyping of mouse models of Parkinson's disease. Behavioural Brain Research. 211: 1-10
Taylor TN, Caudle WM, Shepherd KR, et al. (2009) Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 8103-13
Guillot TS, Richardson JR, Wang MZ, et al. (2008) PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity. Neuropeptides. 42: 423-34
See more...